Flolan
Product Images NDC 0173-0519

5 FDA label images from Glaxosmithkline Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Flolan (NDC 0173-0519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flolan Infusion Rate Formula (Flolan Spl Graphic 01)

Flolan Infusion Rate Formula (Flolan Spl Graphic 01)
A text panel showing example calculations for infusion rates in mL/h based on dose (ng/kg/min), patient weight (kg), and final concentration (ng/mL). Two examples illustrate the formula for calculating infusion rate using different doses and concentrations.*
FDA Label Image

Epoprostenol Sodium Chemical Structure (Flolan Spl Graphic 02)

Epoprostenol Sodium Chemical Structure (Flolan Spl Graphic 02)
Chemical structure of the active ingredient in FLOLAN, showing a molecular diagram with sodium carboxylate and multiple hydroxy and alkyl groups.*
FDA Label Image

Flolan 0.5 mg Label (Flolan Spl Graphic 03)

Flolan 0.5 mg Label (Flolan Spl Graphic 03)
FLOLAN (epoprostenol sodium) for Injection 0.5 mg/vial (500,000 ng/vial) single-use vial label from GlaxoSmithKline. The label states the drug must be reconstituted for intravenous infusion after dilution using sterile diluent or pH 12 sterile diluent. It includes storage instructions at 15° to 25°C and warnings against accepting the vial if the plastic overseal is missing or not securely fitted. Contains detailed ingredient and manufacturing information.*
FDA Label Image

Flolan 1.5 mg Label (Flolan Spl Graphic 04)

Flolan 1.5 mg Label (Flolan Spl Graphic 04)
FLOLAN (epoprostenol sodium) for Injection label from GlaxoSmithKline LLC. The vial contains 1.5 mg/vial (1,500,000 ng/vial) of epoprostenol sodium. The label includes instructions to use only sterile diluent for reconstitution, storage conditions (15° to 25°C), and warnings about plastic overseal security. It also notes the single-use vial and includes lot and expiration date fields.*
FDA Label Image

Flolan Spl Graphic 06

Flolan Spl Graphic 06
Label for pH 12 Sterile Diluent for FLOLAN (epoprostenol sodium) injection. It is a 50 mL single-use vial, labeled for use only with FLOLAN. The label includes storage instructions (15° to 25°C, do not freeze) and warnings regarding vial integrity and usage. Manufactured by GlaxoSmithKline LLC, made in England.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.